74
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In normal human somatic cells, telomere dysfunction causes cellular senescence, a stable proliferative arrest with tumour suppressing properties. Whether telomere dysfunction-induced senescence (TDIS) suppresses cancer growth in humans, however, is unknown. Here, we demonstrate that multiple and distinct human cancer precursor lesions, but not corresponding malignant cancers, are comprised of cells that display hallmarks of TDIS. Furthermore, we demonstrate that oncogenic signalling, frequently associated with initiating cancer growth in humans, dramatically affected telomere structure and function by causing telomeric replication stress, rapid and stochastic telomere attrition, and consequently telomere dysfunction in cells that lack hTERT activity. DNA replication stress induced by drugs also resulted in telomere dysfunction and cellular senescence in normal human cells, demonstrating that telomeric repeats indeed are hypersensitive to DNA replication stress. Our data reveal that TDIS, accelerated by oncogene-induced DNA replication stress, is a biological response of cells in human cancer precursor lesions and provide strong evidence that TDIS is a critical tumour suppressing mechanism in humans.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.

          DNA damage checkpoint genes, such as p53, are frequently mutated in human cancer, but the selective pressure for their inactivation remains elusive. We analysed a panel of human lung hyperplasias, all of which retained wild-type p53 genes and had no signs of gross chromosomal instability, and found signs of a DNA damage response, including histone H2AX and Chk2 phosphorylation, p53 accumulation, focal staining of p53 binding protein 1 (53BP1) and apoptosis. Progression to carcinoma was associated with p53 or 53BP1 inactivation and decreased apoptosis. A DNA damage response was also observed in dysplastic nevi and in human skin xenografts, in which hyperplasia was induced by overexpression of growth factors. Both lung and experimentally-induced skin hyperplasias showed allelic imbalance at loci that are prone to DNA double-strand break formation when DNA replication is compromised (common fragile sites). We propose that, from its earliest stages, cancer development is associated with DNA replication stress, which leads to DNA double-strand breaks, genomic instability and selective pressure for p53 mutations.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Tumour biology: senescence in premalignant tumours.

            Oncogene-induced senescence is a cellular response that may be crucial for protection against cancer development, but its investigation has so far been restricted to cultured cells that have been manipulated to overexpress an oncogene. Here we analyse tumours initiated by an endogenous oncogene, ras, and show that senescent cells exist in premalignant tumours but not in malignant ones. Senescence is therefore a defining feature of premalignant tumours that could prove valuable in the diagnosis and prognosis of cancer.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Senescence in tumours: evidence from mice and humans.

              The importance of cellular senescence, which is a stress response that stably blocks proliferation, is increasingly being recognized. Senescence is prevalent in pre-malignant tumours, and progression to malignancy requires evading senescence. Malignant tumours, however, may still undergo senescence owing to interventions that restore tumour suppressor function or inactivate oncogenes. Senescent tumour cells can be cleared by immune cells, which may result in efficient tumour regression. Standard chemotherapy also has the potential to induce senescence, which may partly underlie its therapeutic activity. Although these concepts are well supported in mouse models, translating them to clinical oncology remains a challenge.
                Bookmark

                Author and article information

                Journal
                EMBO J
                EMBO J
                The EMBO Journal
                Nature Publishing Group
                0261-4189
                1460-2075
                29 June 2012
                08 May 2012
                08 May 2012
                : 31
                : 13
                : 2839-2851
                Affiliations
                [1 ]simpleNew Jersey Medical School-University Hospital Cancer Center, UMDNJ-New Jersey Medical School , Newark, NJ, USA
                [2 ]simpleDepartment of Microbiology and Molecular Genetics, UMDNJ-New Jersey Medical School , Newark, NJ, USA
                [3 ]simpleIFOM Foundation—FIRC Institute of Molecular Oncology Foundation , Milan, Italy
                [4 ]simpleDepartment of Pathology and Laboratory Medicine, UMDNJ-New Jersey Medical School , Newark, NJ, USA
                [5 ]simpleDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore , Singapore
                [6 ]simpleIstituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche , Pavia, Italy
                Author notes
                [a ]Department of Microbiology and Molecular Genetics, New Jersey Medical School-UH Cancer Center, UMDNJ, CC-G1226, 205 South Orange Avenue, Newark, NJ 07103, USA. Tel.:+1 973 972 4426; Fax:+1 973 972 1875; E-mail: herbigut@ 123456umdnj.edu
                [*]

                Current address: TTFactor Srl, Milan, Italy

                [†]

                Current address: Department of Pathology, New York University School of Medicine, New York, NY, USA

                Article
                emboj2012132
                10.1038/emboj.2012.132
                3395091
                22569128
                93cfd241-e8ed-4ac0-8e06-b304f25a83bb
                Copyright © 2012, European Molecular Biology Organization

                This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial Share Alike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission.

                History
                : 14 October 2011
                : 16 April 2012
                Categories
                Article

                Molecular biology
                cancer progression,telomere dysfunction,tumour suppressing mechanism,oncogene,cellular senescence

                Comments

                Comment on this article